Brian Walker, DO - Medicare Family Practice in Fort Mill, SC

Brian Walker, DO is a medicare enrolled "Family Medicine" physician in Fort Mill, South Carolina. He went to Des Moines University Of Osteopathic Medicine And Health Sciences and graduated in 2003 and has 21 years of diverse experience with area of expertise as Family Practice. He is a member of the group practice Duke University Affiliated Physicians Inc and his current practice location is 704 Gold Hill Rd, Ste 1200, Fort Mill, South Carolina. You can reach out to his office (for appointments etc.) via phone at (704) 667-3380.

Brian Walker is licensed to practice in North Carolina (license number 200600366) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1619949617.

Contact Information

Brian Walker, DO
704 Gold Hill Rd, Ste 1200,
Fort Mill, SC 29715-8906
(704) 667-3380
Not Available



Physician's Profile

Full NameBrian Walker
GenderMale
SpecialityFamily Practice
Experience21 Years
Location704 Gold Hill Rd, Fort Mill, South Carolina
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Brian Walker attended and graduated from Des Moines University Of Osteopathic Medicine And Health Sciences in 2003
  NPI Data:
  • NPI Number: 1619949617
  • Provider Enumeration Date: 02/03/2006
  • Last Update Date: 09/27/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 7911943881
  • Enrollment ID: I20080521000676

Medical Identifiers

Medical identifiers for Brian Walker such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1619949617NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 991 (South Carolina)Secondary
207Q00000XFamily Medicine 200600366 (North Carolina)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Duke Health Raleigh HospitalRaleigh, NCHospital
Duke University HospitalDurham, NCHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Duke University Affiliated Physicians Inc3779489588459

News Archive

Scientists are a step closer to developing drug targets to treat fungal meningitis

Scientists are a step closer to developing drug targets to treat fungal meningitis - the infection linked to at least three deaths on Vancouver Island - thanks to the sequencing of two Cryptococcus genomes by an international team that included researchers at the University of British Columbia and the BC Cancer Agency's Michael Smith Genome Sciences Centre in Vancouver.

Researchers discover key enzyme driving breast cancer

Looking to identify new strategies to prevent breast cancer recurrence, a research team led by Subhamoy Dasgupta, PhD, Assistant Professor of Oncology in the Department of Cell Stress Biology at Roswell Park Comprehensive Cancer Center, has identified two key proteins involved in glucose metabolism that could be targeted to prevent breast cancer metastasis and recurrence. The team's findings were published today in the journal Nature.

MedImmune to present Phase IIb asthma data on benralizumab and tralokinumab at ATS conference

AstraZeneca today announced that MedImmune, its global biologics research and development arm, will present Phase IIb data on two novel investigational molecules – benralizumab and tralokinumab – at the upcoming American Thoracic Society 2014 International Conference being held in San Diego, California, 16-21 May.

CBO says Senate reform bill to cost $849 billion and cut the deficit by $127 billion

Roll Call : "Senate Majority Leader Harry Reid's (D-Nev.) health care reform proposal will cost $849 billion over 10 years but cut the deficit by about $127 billion, leadership aides announced Wednesday afternoon.

NIAID experts call for innovative research on STIs

Sexually transmitted infections, or STIs, pose a significant public health challenge. Globally, more than one million new STI cases are diagnosed each day.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Brian Walker allows following entities to bill medicare on his behalf.
Entity NameDuke University Affiliated Physicians Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1316975972
PECOS PAC ID: 3779489588
Enrollment ID: O20031211000642

News Archive

Scientists are a step closer to developing drug targets to treat fungal meningitis

Scientists are a step closer to developing drug targets to treat fungal meningitis - the infection linked to at least three deaths on Vancouver Island - thanks to the sequencing of two Cryptococcus genomes by an international team that included researchers at the University of British Columbia and the BC Cancer Agency's Michael Smith Genome Sciences Centre in Vancouver.

Researchers discover key enzyme driving breast cancer

Looking to identify new strategies to prevent breast cancer recurrence, a research team led by Subhamoy Dasgupta, PhD, Assistant Professor of Oncology in the Department of Cell Stress Biology at Roswell Park Comprehensive Cancer Center, has identified two key proteins involved in glucose metabolism that could be targeted to prevent breast cancer metastasis and recurrence. The team's findings were published today in the journal Nature.

MedImmune to present Phase IIb asthma data on benralizumab and tralokinumab at ATS conference

AstraZeneca today announced that MedImmune, its global biologics research and development arm, will present Phase IIb data on two novel investigational molecules – benralizumab and tralokinumab – at the upcoming American Thoracic Society 2014 International Conference being held in San Diego, California, 16-21 May.

CBO says Senate reform bill to cost $849 billion and cut the deficit by $127 billion

Roll Call : "Senate Majority Leader Harry Reid's (D-Nev.) health care reform proposal will cost $849 billion over 10 years but cut the deficit by about $127 billion, leadership aides announced Wednesday afternoon.

NIAID experts call for innovative research on STIs

Sexually transmitted infections, or STIs, pose a significant public health challenge. Globally, more than one million new STI cases are diagnosed each day.

Read more Medical News

› Verified 6 days ago

Entity NameCarolinas Physicians Network Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1437607686
PECOS PAC ID: 3375449655
Enrollment ID: O20040115000819

News Archive

Scientists are a step closer to developing drug targets to treat fungal meningitis

Scientists are a step closer to developing drug targets to treat fungal meningitis - the infection linked to at least three deaths on Vancouver Island - thanks to the sequencing of two Cryptococcus genomes by an international team that included researchers at the University of British Columbia and the BC Cancer Agency's Michael Smith Genome Sciences Centre in Vancouver.

Researchers discover key enzyme driving breast cancer

Looking to identify new strategies to prevent breast cancer recurrence, a research team led by Subhamoy Dasgupta, PhD, Assistant Professor of Oncology in the Department of Cell Stress Biology at Roswell Park Comprehensive Cancer Center, has identified two key proteins involved in glucose metabolism that could be targeted to prevent breast cancer metastasis and recurrence. The team's findings were published today in the journal Nature.

MedImmune to present Phase IIb asthma data on benralizumab and tralokinumab at ATS conference

AstraZeneca today announced that MedImmune, its global biologics research and development arm, will present Phase IIb data on two novel investigational molecules – benralizumab and tralokinumab – at the upcoming American Thoracic Society 2014 International Conference being held in San Diego, California, 16-21 May.

CBO says Senate reform bill to cost $849 billion and cut the deficit by $127 billion

Roll Call : "Senate Majority Leader Harry Reid's (D-Nev.) health care reform proposal will cost $849 billion over 10 years but cut the deficit by about $127 billion, leadership aides announced Wednesday afternoon.

NIAID experts call for innovative research on STIs

Sexually transmitted infections, or STIs, pose a significant public health challenge. Globally, more than one million new STI cases are diagnosed each day.

Read more Medical News

› Verified 6 days ago

Entity NameMecklenburg Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1255364535
PECOS PAC ID: 9931196797
Enrollment ID: O20040426001334

News Archive

Scientists are a step closer to developing drug targets to treat fungal meningitis

Scientists are a step closer to developing drug targets to treat fungal meningitis - the infection linked to at least three deaths on Vancouver Island - thanks to the sequencing of two Cryptococcus genomes by an international team that included researchers at the University of British Columbia and the BC Cancer Agency's Michael Smith Genome Sciences Centre in Vancouver.

Researchers discover key enzyme driving breast cancer

Looking to identify new strategies to prevent breast cancer recurrence, a research team led by Subhamoy Dasgupta, PhD, Assistant Professor of Oncology in the Department of Cell Stress Biology at Roswell Park Comprehensive Cancer Center, has identified two key proteins involved in glucose metabolism that could be targeted to prevent breast cancer metastasis and recurrence. The team's findings were published today in the journal Nature.

MedImmune to present Phase IIb asthma data on benralizumab and tralokinumab at ATS conference

AstraZeneca today announced that MedImmune, its global biologics research and development arm, will present Phase IIb data on two novel investigational molecules – benralizumab and tralokinumab – at the upcoming American Thoracic Society 2014 International Conference being held in San Diego, California, 16-21 May.

CBO says Senate reform bill to cost $849 billion and cut the deficit by $127 billion

Roll Call : "Senate Majority Leader Harry Reid's (D-Nev.) health care reform proposal will cost $849 billion over 10 years but cut the deficit by about $127 billion, leadership aides announced Wednesday afternoon.

NIAID experts call for innovative research on STIs

Sexually transmitted infections, or STIs, pose a significant public health challenge. Globally, more than one million new STI cases are diagnosed each day.

Read more Medical News

› Verified 6 days ago

Entity NameEastland Urgent Care
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1467481127
PECOS PAC ID: 6305852591
Enrollment ID: O20060224000538

News Archive

Scientists are a step closer to developing drug targets to treat fungal meningitis

Scientists are a step closer to developing drug targets to treat fungal meningitis - the infection linked to at least three deaths on Vancouver Island - thanks to the sequencing of two Cryptococcus genomes by an international team that included researchers at the University of British Columbia and the BC Cancer Agency's Michael Smith Genome Sciences Centre in Vancouver.

Researchers discover key enzyme driving breast cancer

Looking to identify new strategies to prevent breast cancer recurrence, a research team led by Subhamoy Dasgupta, PhD, Assistant Professor of Oncology in the Department of Cell Stress Biology at Roswell Park Comprehensive Cancer Center, has identified two key proteins involved in glucose metabolism that could be targeted to prevent breast cancer metastasis and recurrence. The team's findings were published today in the journal Nature.

MedImmune to present Phase IIb asthma data on benralizumab and tralokinumab at ATS conference

AstraZeneca today announced that MedImmune, its global biologics research and development arm, will present Phase IIb data on two novel investigational molecules – benralizumab and tralokinumab – at the upcoming American Thoracic Society 2014 International Conference being held in San Diego, California, 16-21 May.

CBO says Senate reform bill to cost $849 billion and cut the deficit by $127 billion

Roll Call : "Senate Majority Leader Harry Reid's (D-Nev.) health care reform proposal will cost $849 billion over 10 years but cut the deficit by about $127 billion, leadership aides announced Wednesday afternoon.

NIAID experts call for innovative research on STIs

Sexually transmitted infections, or STIs, pose a significant public health challenge. Globally, more than one million new STI cases are diagnosed each day.

Read more Medical News

› Verified 6 days ago

Entity NameArboretum Urgent Care Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1457380313
PECOS PAC ID: 8325059991
Enrollment ID: O20060510000344

News Archive

Scientists are a step closer to developing drug targets to treat fungal meningitis

Scientists are a step closer to developing drug targets to treat fungal meningitis - the infection linked to at least three deaths on Vancouver Island - thanks to the sequencing of two Cryptococcus genomes by an international team that included researchers at the University of British Columbia and the BC Cancer Agency's Michael Smith Genome Sciences Centre in Vancouver.

Researchers discover key enzyme driving breast cancer

Looking to identify new strategies to prevent breast cancer recurrence, a research team led by Subhamoy Dasgupta, PhD, Assistant Professor of Oncology in the Department of Cell Stress Biology at Roswell Park Comprehensive Cancer Center, has identified two key proteins involved in glucose metabolism that could be targeted to prevent breast cancer metastasis and recurrence. The team's findings were published today in the journal Nature.

MedImmune to present Phase IIb asthma data on benralizumab and tralokinumab at ATS conference

AstraZeneca today announced that MedImmune, its global biologics research and development arm, will present Phase IIb data on two novel investigational molecules – benralizumab and tralokinumab – at the upcoming American Thoracic Society 2014 International Conference being held in San Diego, California, 16-21 May.

CBO says Senate reform bill to cost $849 billion and cut the deficit by $127 billion

Roll Call : "Senate Majority Leader Harry Reid's (D-Nev.) health care reform proposal will cost $849 billion over 10 years but cut the deficit by about $127 billion, leadership aides announced Wednesday afternoon.

NIAID experts call for innovative research on STIs

Sexually transmitted infections, or STIs, pose a significant public health challenge. Globally, more than one million new STI cases are diagnosed each day.

Read more Medical News

› Verified 6 days ago

Entity NameSteele Creek Urgent Care
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1750317921
PECOS PAC ID: 9234130907
Enrollment ID: O20070123000481

News Archive

Scientists are a step closer to developing drug targets to treat fungal meningitis

Scientists are a step closer to developing drug targets to treat fungal meningitis - the infection linked to at least three deaths on Vancouver Island - thanks to the sequencing of two Cryptococcus genomes by an international team that included researchers at the University of British Columbia and the BC Cancer Agency's Michael Smith Genome Sciences Centre in Vancouver.

Researchers discover key enzyme driving breast cancer

Looking to identify new strategies to prevent breast cancer recurrence, a research team led by Subhamoy Dasgupta, PhD, Assistant Professor of Oncology in the Department of Cell Stress Biology at Roswell Park Comprehensive Cancer Center, has identified two key proteins involved in glucose metabolism that could be targeted to prevent breast cancer metastasis and recurrence. The team's findings were published today in the journal Nature.

MedImmune to present Phase IIb asthma data on benralizumab and tralokinumab at ATS conference

AstraZeneca today announced that MedImmune, its global biologics research and development arm, will present Phase IIb data on two novel investigational molecules – benralizumab and tralokinumab – at the upcoming American Thoracic Society 2014 International Conference being held in San Diego, California, 16-21 May.

CBO says Senate reform bill to cost $849 billion and cut the deficit by $127 billion

Roll Call : "Senate Majority Leader Harry Reid's (D-Nev.) health care reform proposal will cost $849 billion over 10 years but cut the deficit by about $127 billion, leadership aides announced Wednesday afternoon.

NIAID experts call for innovative research on STIs

Sexually transmitted infections, or STIs, pose a significant public health challenge. Globally, more than one million new STI cases are diagnosed each day.

Read more Medical News

› Verified 6 days ago

Entity NameWestern Carolina Emergency Physicians, Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1134391758
PECOS PAC ID: 8921171190
Enrollment ID: O20080721000746

News Archive

Scientists are a step closer to developing drug targets to treat fungal meningitis

Scientists are a step closer to developing drug targets to treat fungal meningitis - the infection linked to at least three deaths on Vancouver Island - thanks to the sequencing of two Cryptococcus genomes by an international team that included researchers at the University of British Columbia and the BC Cancer Agency's Michael Smith Genome Sciences Centre in Vancouver.

Researchers discover key enzyme driving breast cancer

Looking to identify new strategies to prevent breast cancer recurrence, a research team led by Subhamoy Dasgupta, PhD, Assistant Professor of Oncology in the Department of Cell Stress Biology at Roswell Park Comprehensive Cancer Center, has identified two key proteins involved in glucose metabolism that could be targeted to prevent breast cancer metastasis and recurrence. The team's findings were published today in the journal Nature.

MedImmune to present Phase IIb asthma data on benralizumab and tralokinumab at ATS conference

AstraZeneca today announced that MedImmune, its global biologics research and development arm, will present Phase IIb data on two novel investigational molecules – benralizumab and tralokinumab – at the upcoming American Thoracic Society 2014 International Conference being held in San Diego, California, 16-21 May.

CBO says Senate reform bill to cost $849 billion and cut the deficit by $127 billion

Roll Call : "Senate Majority Leader Harry Reid's (D-Nev.) health care reform proposal will cost $849 billion over 10 years but cut the deficit by about $127 billion, leadership aides announced Wednesday afternoon.

NIAID experts call for innovative research on STIs

Sexually transmitted infections, or STIs, pose a significant public health challenge. Globally, more than one million new STI cases are diagnosed each day.

Read more Medical News

› Verified 6 days ago

Entity NameCenterwell Senior Primary Care Nc Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1073034625
PECOS PAC ID: 2264708486
Enrollment ID: O20171016002152

News Archive

Scientists are a step closer to developing drug targets to treat fungal meningitis

Scientists are a step closer to developing drug targets to treat fungal meningitis - the infection linked to at least three deaths on Vancouver Island - thanks to the sequencing of two Cryptococcus genomes by an international team that included researchers at the University of British Columbia and the BC Cancer Agency's Michael Smith Genome Sciences Centre in Vancouver.

Researchers discover key enzyme driving breast cancer

Looking to identify new strategies to prevent breast cancer recurrence, a research team led by Subhamoy Dasgupta, PhD, Assistant Professor of Oncology in the Department of Cell Stress Biology at Roswell Park Comprehensive Cancer Center, has identified two key proteins involved in glucose metabolism that could be targeted to prevent breast cancer metastasis and recurrence. The team's findings were published today in the journal Nature.

MedImmune to present Phase IIb asthma data on benralizumab and tralokinumab at ATS conference

AstraZeneca today announced that MedImmune, its global biologics research and development arm, will present Phase IIb data on two novel investigational molecules – benralizumab and tralokinumab – at the upcoming American Thoracic Society 2014 International Conference being held in San Diego, California, 16-21 May.

CBO says Senate reform bill to cost $849 billion and cut the deficit by $127 billion

Roll Call : "Senate Majority Leader Harry Reid's (D-Nev.) health care reform proposal will cost $849 billion over 10 years but cut the deficit by about $127 billion, leadership aides announced Wednesday afternoon.

NIAID experts call for innovative research on STIs

Sexually transmitted infections, or STIs, pose a significant public health challenge. Globally, more than one million new STI cases are diagnosed each day.

Read more Medical News

› Verified 6 days ago

Entity NameCenterwell Senior Primary Care Nc Jv Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1366181943
PECOS PAC ID: 0345614384
Enrollment ID: O20230315000375

News Archive

Scientists are a step closer to developing drug targets to treat fungal meningitis

Scientists are a step closer to developing drug targets to treat fungal meningitis - the infection linked to at least three deaths on Vancouver Island - thanks to the sequencing of two Cryptococcus genomes by an international team that included researchers at the University of British Columbia and the BC Cancer Agency's Michael Smith Genome Sciences Centre in Vancouver.

Researchers discover key enzyme driving breast cancer

Looking to identify new strategies to prevent breast cancer recurrence, a research team led by Subhamoy Dasgupta, PhD, Assistant Professor of Oncology in the Department of Cell Stress Biology at Roswell Park Comprehensive Cancer Center, has identified two key proteins involved in glucose metabolism that could be targeted to prevent breast cancer metastasis and recurrence. The team's findings were published today in the journal Nature.

MedImmune to present Phase IIb asthma data on benralizumab and tralokinumab at ATS conference

AstraZeneca today announced that MedImmune, its global biologics research and development arm, will present Phase IIb data on two novel investigational molecules – benralizumab and tralokinumab – at the upcoming American Thoracic Society 2014 International Conference being held in San Diego, California, 16-21 May.

CBO says Senate reform bill to cost $849 billion and cut the deficit by $127 billion

Roll Call : "Senate Majority Leader Harry Reid's (D-Nev.) health care reform proposal will cost $849 billion over 10 years but cut the deficit by about $127 billion, leadership aides announced Wednesday afternoon.

NIAID experts call for innovative research on STIs

Sexually transmitted infections, or STIs, pose a significant public health challenge. Globally, more than one million new STI cases are diagnosed each day.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Brian Walker is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Brian Walker, DO
Po Box 19305,
Charlotte, NC 28219-9305

Ph: () -
Brian Walker, DO
704 Gold Hill Rd, Ste 1200,
Fort Mill, SC 29715-8906

Ph: (704) 667-3380

News Archive

Scientists are a step closer to developing drug targets to treat fungal meningitis

Scientists are a step closer to developing drug targets to treat fungal meningitis - the infection linked to at least three deaths on Vancouver Island - thanks to the sequencing of two Cryptococcus genomes by an international team that included researchers at the University of British Columbia and the BC Cancer Agency's Michael Smith Genome Sciences Centre in Vancouver.

Researchers discover key enzyme driving breast cancer

Looking to identify new strategies to prevent breast cancer recurrence, a research team led by Subhamoy Dasgupta, PhD, Assistant Professor of Oncology in the Department of Cell Stress Biology at Roswell Park Comprehensive Cancer Center, has identified two key proteins involved in glucose metabolism that could be targeted to prevent breast cancer metastasis and recurrence. The team's findings were published today in the journal Nature.

MedImmune to present Phase IIb asthma data on benralizumab and tralokinumab at ATS conference

AstraZeneca today announced that MedImmune, its global biologics research and development arm, will present Phase IIb data on two novel investigational molecules – benralizumab and tralokinumab – at the upcoming American Thoracic Society 2014 International Conference being held in San Diego, California, 16-21 May.

CBO says Senate reform bill to cost $849 billion and cut the deficit by $127 billion

Roll Call : "Senate Majority Leader Harry Reid's (D-Nev.) health care reform proposal will cost $849 billion over 10 years but cut the deficit by about $127 billion, leadership aides announced Wednesday afternoon.

NIAID experts call for innovative research on STIs

Sexually transmitted infections, or STIs, pose a significant public health challenge. Globally, more than one million new STI cases are diagnosed each day.

Read more News

› Verified 6 days ago


Family Medicine Doctors in Fort Mill, SC

Sharon Olang, DO
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 704 Gold Hill Rd, Fort Mill, SC 29715
Phone: 803-835-0420    
Dr. Ann Elizabeth Meyer, D.O.
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1690 Highway 160 W, Fort Mill, SC 29708
Phone: 803-547-7541    
Dr. Kenneth Edward Nunnery, MD
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1690 Highway 160 W, Fort Mill, SC 29708
Phone: 803-547-7541    Fax: 803-548-0122
Dr. Lance M Gowen, M.D.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 515 Rivercrossing Dr Ste 180, Fort Mill, SC 29715
Phone: 803-547-7541    Fax: 803-548-0122
Inna Slisz, DO
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 704 Gold Hill Rd, Fort Mill, SC 29715
Phone: 803-835-0420    
Dr. George Marshall Yearta, MD
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1690 Highway 160 W, Fort Mill, SC 29708
Phone: 803-547-7541    Fax: 803-548-0122
Dr. Pratik Arunkumar Mehta, M.D.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 502 Sixth Baxter Xing, Suite A, Fort Mill, SC 29708
Phone: 803-835-2088    Fax: 803-835-2099

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.